The association between high<unk>  lipoprotein (HDL) level and cardiovascular disease has been widely reported in the literature.  In fact, 1 out of every 7 statin treated patients has residual cardiovascular disease, which sheds light on the importance of developing new<unk>  targeting HDL quantity and quality in high risk patients.
High density lipoprotein future or investigational therapies
Low density lipoprotein future or investigational therapies
High density lipoprotein medical therapy
Low density lipoprotein medical therapy
Blood cholesterol LDL and non-HDL treatment goals
High cholesterol secondary prevention
High cholesterol primary prevention
Metabolic syndrome dietary therapy